Voices Against Brain Cancer Discusses Possibility of Brain Cancer Treatment Becoming Personalized
Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses the possibility of brain cancer treatment becoming personally-tailored to each patient’s individual case.
New York, NY (PRWEB) August 17, 2013
On August 17, Voices Against Brain Cancer (VABC), an organization dedicated to brain cancer research and advocacy, discusses the possibility of brain cancer treatment becoming personally-tailored to patients’ individual needs and cases.
According to an August 12, 2013 article published on Futurity.org, titled, “Medicine gets personal to stop brain tumor ‘drivers’,” researchers have identified 18 new genes that drive the most aggressive and common form of brain cancer in adults: glioblastoma multiforme.
Antonio Iavarone, professor of pathology and neurology at Columbia University Medical Center and lead author of a study published in the journal Nature Genetics, elaborates on his team’s findings, saying, “Once you know the driver in a particular tumor and you hit it, the cancer collapses. We think our study has identified the vast majority of drivers in glioblastoma, and therefore a list of the most important targets for glioblastoma drug development and the basis for personalized treatment of brain cancer.”
The article says that because patients’ tumors are powered by different driver genes, a complicated analysis will still be needed for personalized glioblastoma treatment to become a reality.
However, Michael Klipper, Chairman of Voices Against Brain Cancer, remains hopeful after learning about this new discovery. “We’re learning about different scientific breakthroughs every day that allow us to believe that there will one day be a way of curing this terrible disease. Any discovery is a good discovery. Here at VABC, we commend the scientists who work every day to find a cure.”
VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.
VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact: 5W Public Relations.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/8/prweb11034871.htm